Copyright
©The Author(s) 2021.
World J Gastroenterol. Jun 7, 2021; 27(21): 2681-2709
Published online Jun 7, 2021. doi: 10.3748/wjg.v27.i21.2681
Published online Jun 7, 2021. doi: 10.3748/wjg.v27.i21.2681
Term of ANN | Specific meaning |
Size | Number of neurons in the whole model |
Width | Number of neurons in the one layer |
Depth | Number of layers |
Framework | Arrangement methods of layers and neurons |
Capability | The reflection contents of reality by the specific model |
Category | Feedforward neural network | Feedback neural network |
Signal direction | Unidirectional | Unidirectional/bidirectional |
Operation time | Short | Long |
Feedback by output signal | No | Yes |
Structural complexity | Simple | Complicated |
Memory time | Short-term or none | Long-term |
Applied ranges in medicine | Wide | Limited |
Application | Perceptron network, back propagation network, radial basis function network | Recurrent neural network, Hopfieid network, Boltzmann machine |
Ref. | Disease | Type of data | ANN technique | Application direction | Outcome |
Bao et al[167], 2020 | CRC | Microsatellite instability from TCGA database | Multi-layer perceptron network | Prognostic prediction | 100% accuracy |
Coppedè et al[189], 2015 | CRC | DNA methylation | AutoCM | Identification of connections between DNA methylation and CRC | A strong connection between the low methylation levels ofthe five CRC genes |
Liu et al[190], 2004 | CRC | Gene signature from GEDatasets | Multi-layer network | Identification of latent marker genes of CRC | 91.94% accuracy |
Berishvili et al[164], 2019 | CRC | Approximately 4000 complexes for which the data on the target binding constants | CNN | Screening filter for compoundprioritization | 73% Spearman rank correlation coefficient |
Bloom et al[159], 2007 | CRC and GC | MS | Multi-layer network | Differentiation between 6 common tumor types | 87% accuracy |
Dadkhah et al[120], 2019 | colorectal polyp | Gut microbiome | ANN developed by Orange data mining tool | Early screening using collected stool | > 75% accuracy |
Chang et al[166], 2011 | CRC | miRNA profile | Not mentioned | Exploration of association between specific miRNAs and clinicopathological features | 100% accuracy of miRNA panel |
Chen et al[191], 2004 | CRC | MS of serum protein pattern | Multi-layer perceptron network | Differentiation between CRC and healthy control | 91% sensitivity; 93% specificity; 0.967 AUC |
He et al[121], 2020 | CRC and gastroesophageal cancer | Gene signature from TCGA database | Multi-layer network | Differentiation between types of cancer | CRC: 98.06% sensitivity; 96.88% precision. Gastroesophageal cancer: 94.89% sensitivity; 96.33% precision |
Hu et al[192], 2015 | CRC | Gene signature from database of NCBI NLM NIH | S-Kohonen neural network | Prediction of recurrence using gene expressions | 91% accuracy |
Kurokawa et al[128], 2005 | CRC | Gene signature of nodal metastasis | BNN | Prediction of metastatic potential of CRC at stage I | 88.0% sensitivity; 86.6% specificity; 0.904 AUC |
Liu et al[160], 2019 | Cancer cell | Synthetic microscopic images from two publicly datasets | CNN | Automated counting of cancer cells | - |
Ronen et al[193], 2019 | CRC | Gene signature from TCGA database | BNN | Stratification of CRC subtypes | - |
Bilsland et al[194], 2015 | CRC | A virtual library of compounds | Perceptron network | Screen of Benzimidazolone inhibitors for CRC treatment | CB-20903630 was selected out for further validation of CRC treatment |
Maniruzzaman et al[195], 2019 | CRC | Gene signature from patients | Fuzzy neural network | CRC classification | 99.84% sensitivity; 99.75% specific; 99.81% accuracy; 0.9995 AUC |
Inglese et al[196], 2017 | CRC | 3D MS | Deep neural network (unsupervised) | Identification of metabolic heterogeneity | Up to 0.6991 Pearson's correlation |
Shi et al[197], 2020 | CRC with liver metastasis | CT | ANN | Prediction of KRAS, NRAS and BRAF status | 0.95 AUC |
Jiang et al[198], 2020 | GC | Two drug datasets | deep neural network | Prediction of drug-disease associations | 17 kinds of drugs that were screened out by ANN had been confirmed as anti-tumor drugs |
Bidaut et al[158], 2009 | Stomach stem cell | Stemness signature | Perceptron network | Characterization of stem cells | - |
Jing et al[168], 2019 | Calibration of laboratory markers | CA-724 | Radial basis function neural network | The effects of geographic factors on CA-724 | CA724 reference values show spatial autocorrelation and regional variation |
Xiao et al[122], 2018 | GC | RNA-seq | Probabilistic neural networks (semi- supervised) | Diagnosis of cancer | 96.23% accuracy; 99.08% precision |
Hang et al[144], 2018 | GC | MSI | Multi-layer perceptron network | Prognostic prediction | 0.81 AUC |
Xuan et al[161], 2019 | GC | LncRNA profile | CNN | Prediction of GC | 0.977 AUC |
Joo et al[163], 2019 | GC | Potential drugs from databases | CNN | Exploration of new drugs targeting | ANN-based model accurately predicts drug responsiveness as models previously reported |
Liu et al[165], 2010 | GC | MS from GC patients | Supervised neural network | Early screening | 100% sensitivity; 75% specificity |
Que et al[199], 2019 | GC | MS from GC patients and clinicopathological parameters | Single-layer neural network | Prediction of long-term survival | 0.82 AUC |
Li et al[200], 2021 | GC | Gene Expression Omnibus database | ANN | Differentiation between GC and healthy tissues | 0.946 AUC |
Ref. | Disease | Aim | Number of samples | ANN technique | Included variables | Outcome |
Ahmed et al[169], 2017 | CD | Diagnosis | 144 CD patients; 243 HC individuals | BPNN | 103 variables | Accuracy 97.67%; sensitivity 96.07%; specificity 100% |
Ananthakrishnan et al[154], 2017 | UC and CD | Predicting treatment response to vedolizumab | 43 UC patients; 42 CD patients | vedoNet | Gut microbiome | AUC of CD 88.1%; AUC of UC 85.3% |
Anekboon et al[201], 2014 | CD | Predicting single nucleotide polymorphisms | 144 CD patients; 243 HC individuals | Multi-layer perceptron network | 103 SNPs | Accuracy 90.4%; sensitivity 87.5%; specificity 92.2% |
Dong et al[173], 2019 | CD | Predicting the risk of surgical intervention in Chinese patients | 83 patients with surgery; 83 patients without surgery | ANN | 131 variables | Accuracy 90.89%; precision 46.83%; F1 score 0.5757 |
Fioravanti et al[202], 2018 | IBD | Classification of metagenomics data | 222 IBD patients; 38 HC individuals | CNN | Gut microbiota | - |
Hardalaç et al[203], 2015 | IBD | Predicting the effect of azathioprine on mucosal healing | 129 IBD patients | BPNN | Age, age at diagnosis, usage of other medications prior to azathioprine use, smoking, sex, UC-CD | Accuracy 79.1% |
Kirchberger-Tolstik et al[170], 2020 | UC | Diagnosis | 227 Raman maps with 567500 spectra | CNN | Images of Raman spectroscopy | sensitivity of 78%; specificity 93% |
Klein et al[204], 2017 | CD | Predicting the clinical phenotype | 47 B1 patients; 19 B2 patients; 39 B3 patients | Two-layer FNN | H&E | B1 vs B2 phenotype: sensitivity 81%, specificity 74%, accuracy 75%, AUC 0.74; B1 vs B3 phenotype: sensitivity 69%, specificity 76%, accuracy 70.5%, AUC 0.78; B2 vs B3 phenotype: sensitivity 67%, specificity 72.5%, accuracy 69%, AUC 0.72 |
Lamash et al[71], 2019 | CD | Visualization and quantitative estimation of CD | 23 pediatric CD patients | CNN | MRI | DSCs of 75 ± 18%, 81 ± 8%, and 97 ± 2% for the lumen, wall, and background, respectively |
Le et al[174], 2020 | IBD | Predicting IBD and treatment status | 68 CD patients; 53 UC patients; 34 HC individuals | Neural encoder-decoder (NED) network | Gut microbiota | CD vs HC: 95.2% AUC; UC vs HC: 92.5% AUC; CD vs UC: 81.8% AUC |
Morilla et al[175], 2019 | UC | Predicting treatment responses to infliximab for patients with acute severe UC | 47 patients with acute severe ulcerative colitis | Deep neural network | MicroRNA profiles | 84% accuracy; 0.82 AUC |
Ozawa et al[112], 2019 | UC | Identification of endoscopic inflammation severity | 841 patients | CNN (GoogLeNet) | Colonoscopy images | 0.86 AUC of Mayo 0; 0.98 AUC of Mayo 0-1 |
Peng et al[205], 2015 | IBD | Predicting the frequency of relapse | 569 UC patients; 332 CD patients | ANN | Meteorological data | High accuracy in predicting the frequency of relapse of IBD (MSE = 0.009, MAPE = 17.1 %) |
Shepherd et al[171], 2014 | IBD | Differential diagnosis between IBD and IBS | 59 UC patients; 42 CD patients; 34 IBS patients; 46 HC individuals | Multi-layer perceptron neural network | Gas chromatograph coupled to a metal oxide sensor in stool samples | 76% sensitivity, 88% specificity, 76% accuracy |
Takayama et al[132], 2015 | UC | Predicting treatment response to cytoapheresis | 90 UC patients | Multi-layer perceptron neural network | 13 clinical variables | 96% sensitivity; 97% sensitivity |
Tong et al[172], 2020 | CD, UC and ITB | Differential diagnosis between CD, UC and ITB | 5128 UC patients; 875 CD patients; ITB 396 patients | CNN | Differential features of endoscopic images between UC, CD and ITB | The precisions/recalls of UC-CD-ITB when employing the CNN were 0.99/0.97, 0.87/0.83, and 0.52/0.81, respectively |
- Citation: Cao B, Zhang KC, Wei B, Chen L. Status quo and future prospects of artificial neural network from the perspective of gastroenterologists. World J Gastroenterol 2021; 27(21): 2681-2709
- URL: https://www.wjgnet.com/1007-9327/full/v27/i21/2681.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i21.2681